The preferential sensitivity of MCL, DLBCL, and BCP-ALL cell lines to a similar BLyS-gelonin fusion toxin (rGel/BLyS) was reported previously [27], [52]. This evidence concerns the gene TNFSF13B and mantle cell lymphoma.